Does Refurbishing Your Buy to Let Property Really Improve Odds?
January 7, 2010
Refurbishing your buy to let property really can improve the potential of your investment, and help put tenants back in your rental property. Simple but effective changes can make all the difference.
Don’t let your buy to let property go to waste. Where some areas have experienced great growth, others, due to external factors, have suffered [...]
Large Insider Trades Found in Atmel, Baker Hughes, Amgen, First Solar, Human Genome Sciences, & Aruba; Reported by …
September 3, 2010
Insiderslab.com issues new research reports that highlight large insider trades found in for Atmel, Baker Hughes, Amgen, First Solar, Human Genome Sciences, & Aruba.
Critical Insider Trade Alerts for Microsoft, Las Vegas Sands, Applied Materials, 3PAR, Target, & Dendreon; Reported by …
September 3, 2010
Insiderslab.com issues new research reports that highlight large insider trades found in for Microsoft, Las Vegas Sands, Applied Materials, 3PAR, Target, & Dendreon.
Crime › Insider trading by kin of corporate execs, employees jumps in FY’09
September 3, 2010
Japan’s securities trading watchdog called on corporate executives and officers Friday not to leak unannounced company information even to their close relatives or friends, as…
Local ex-hedge fund trader, Wharton classmate pal nailed for insider trading
September 2, 2010
Wake up and good morning. Here’s a classic case of insider trading right in our own Tampa Bay backyard that netted one local trader nearly $14 million. If only his own subsequent trades had not blown all the money he made
2 settle SEC insider-trading charges
September 2, 2010
A former hedge fund manager and a drug company executive have agreed to settle federal regulators’ charges that they engaged in insider trading ahead of the April 2007 merger announcement by AstraZeneca PLC and MedImmune Inc.
2 Charged in MedImmune Insider Trading Scheme
September 1, 2010
The Securities and Exchange Commission on Wednesday charged Stephen R. Goldfield, a former hedge fund manager, with illegally making a $14 million profit from trading in MedImmune before its takeover by AstraZenca ..)
Ex-hedge fund manager in SEC insider trading accord
September 1, 2010
Ex-hedge fund manager in SEC insider trading accord
Sec Sues Ex-Hedge Fund Manager for Insider Trading in MedImmune
September 1, 2010
A former hedge-fund manager reaped $14 million illegally trading on confidential information about the pending takeover of MedImmune Inc. in 2007, the U.S. Securites and Exchange Commission claimed in a lawsuit today.
US accuses ex-hedge-fund manager of making $14M from insider trading
September 1, 2010
The Securities and Exchange Commission Wednesday accused a former hedge-fund manager of trading on inside information allegedly passed to him by a pharmaceutical executive before a big drug-company deal in 2007. The accused former hedge-fund manager, Stephen R.
Ex-hedge fund manager charged with insider trading
September 1, 2010
A former hedge fund manager has been accused by a U.S. regulator of illegal insider trading in MedImmune Inc securities prior to the acquisition of the pharmaceutical company by Britain’s AstraZeneca Plc.